期刊文献+

曲安奈德对瘢痕疙瘩成纤维细胞Ⅰ、Ⅲ型前胶原基因表达的影响 被引量:7

Assessment of triamcinolone acetonide on the expression of Ⅰ and Ⅲ procollagen genes in human keloid fibroblasts
暂未订购
导出
摘要 目的:评价曲安奈德对瘢痕疙瘩成纤维细胞增殖及Ⅰ、Ⅲ型前胶原mRNA表达的影响。方法:取人瘢痕疙瘩及正常皮肤组织培养的第58代的成纤维细胞,在含有不同浓度的曲安奈德的环境中培养。应用噻唑蓝(MTT)法检测细胞增殖、RT-PCR检测Ⅰ、Ⅲ型前胶原mRNA表达。结果:浓度为0.05~1.0g/L的曲安奈德能明显抑制瘢痕疙瘩和正常皮肤成纤维细胞的增殖;浓度为0.10~1.0g/L的曲安奈德能降低瘢痕疙瘩和正常皮肤成纤维细胞Ⅰ、Ⅲ型前胶原mRNA表达。所有的抑制作用在浓度1g/L时达到最高。结论:曲安奈德对瘢痕疙瘩和正常皮肤成纤维细胞的增殖及Ⅰ、Ⅲ型前胶原mRNA表达有明显的抑制作用。 Objective: To assess the impact of triameinolone acetonide on the proliferation and expression of Ⅰ, Ⅲ procollagen mRNA in human keloid fibroblasts. Methods: Triamcinolone acetonide of different concentration was added to cultured fibroblasts for 5 - 8th generations of passage from human keloid and normal skin tissue. Proliferation activity of fibroblasts was examined using MTF and RT - PCR assay to analyze the expression of I and III procollagen mRNA. Results: Proliferation of fibroblast from the keloids and normal skin were inhibited significantly. The concentration of 0.05 - 1.0 g/L triamcinolone acetonide was markedly inhibited the proliferation of fibroblasts and the concentration of 0.10 ~ 1.0 g/L triamcinolone acetonide decreased the expression of I, III procollagen mRNA in fibroblasts cultured from keloid and normal skin. The inhibitive effects were the most high when 1 g/L triamcinolone acetonide added. Conclusion: Triamcinolone acetonide can markedly inhibit the proliferation and the expression of I and III procollagen mRNA of fibroblasts from keloids and normal skin.
出处 《中国麻风皮肤病杂志》 2012年第11期771-775,共5页 China Journal of Leprosy and Skin Diseases
关键词 瘢痕疙瘩 成纤维细胞 曲安奈德 Ⅰ、Ⅲ型前胶原mRNA keloid fibroblast triamcinolone acetonide Ⅰ, Ⅲ procollagen mRNA
  • 相关文献

参考文献12

  • 1Qian T, Cai Z, Wong RN, et al. In vivo rat metabolism and phar- macokinetic studies of ginsenoside Rg3. J Chromatogr B Analyt Technol Biomed Life Sci, 2005,816( 1 - 2) : 223 - 232.
  • 2Atiyeh BS, Michel C. Keloid or hypertrophic scar the controversy Review of the literature. Annals of Plastic Surgery, 2005,54(6) : 676 - 680.
  • 3Lira K. Painless steroid injections for hypertrophic scars and ke- loids. Br J Plast Surg,2004,57(5) :475 - 477.
  • 4Waggett AD, RalPhs JR, Kwan AP, et al. Characterization of col- lagens and proteoglyeans at the insertion of the human achilles ten- don. Matrix Biol, 1998,16(8) :457 - 470.
  • 5陈新谦 金有豫.新编药物学第14版[M].北京:人民卫生出版社,1998.247-248.
  • 6朱学骏,顾有守,沈丽玉.实用皮肤性病学.第2版.北京:北京医科大学中国协和医科大学联合出版社,1998.481.
  • 7Morris D, Wu L, Zhao I, et al. Acute and chronic animal models for dermal scarring: quantitative study. Plas Reconstr Surg, 2004, 100(3) :674.
  • 8De wit NJ, Van muijen GN, Ruiter DJ. Immunohistochemistry in melanocytic proliferative lesions. Histopathology, 2004,44 (6) : 517 - 541.
  • 9Asbill C, Kim N, E - Kattan A, et al. Evaluation of a human bio- engineered skin equivalent for drug permeation studies. Pharmacol Res,2000, 17(9) : 1092 - 1097.
  • 10Meyer LJ, Russell SB, Russell JD, et al. Reduced hy',durorran in keloid tissue and cultured keloid fibroblasts. J Invest Dermatol, 2000, 114(5) :953 - 959.

共引文献21

同被引文献53

引证文献7

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部